JAZZ PHARMACEUTICALS OPERATIONS UK LIMITED
Operating previously as GW Pharma Limited, the company functions as a UK pharmaceutical manufacturing subsidiary of the Nasdaq-listed biopharmaceutical group Jazz Pharmaceuticals plc.
Get an alert when JAZZ PHARMACEUTICALS OPERATIONS UK LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£0
-100% vs 2023
Net assets
£465M
-16.7% vs 2023
Employees
252
-6% vs 2023
Profit before tax
£46M
-51.9% vs 2023
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · Δ = latest vs prior filed period · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | Δ vs prior |
|---|---|---|---|---|
| Turnover | £561,603,000 | £452,230,000 | -19.5% | |
| Operating profit | £89,753,000 | £37,613,000 | -58.1% | |
| Profit before tax | £96,585,000 | £46,496,000 | -51.9% | |
| Net profit | £93,711,000 | £72,795,000 | -22.3% | |
| Cash | £200,000 | £0 | -100% | |
| Total assets less current liabilities | £574,235,000 | £479,185,000 | -16.6% | |
| Net assets | £558,375,000 | £465,263,000 | -16.7% | |
| Equity | £558,375,000 | £465,263,000 | -16.7% | |
| Average employees | 268 | 252 | -6% | |
| Wages | £20,242,000 | £20,704,000 | +2.3% | |
| Directors' remuneration | £2,345,000 | £2,884,000 | +23% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 16.0% | 8.3% | |
| Net margin | 16.7% | 16.1% | |
| Return on capital employed | 15.6% | 7.8% | |
| Gearing (liabilities / total assets) | 35.1% | 34.6% | |
| Current ratio | 1.60x | 1.22x | |
| Interest cover | 60.89x | 31.50x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 3 times since incorporation — the current trading name was adopted 2024-09-12
- JAZZ PHARMACEUTICALS OPERATIONS UK LIMITED 2024-09-12 → present
- GW PHARMA LIMITED 2001-06-01 → 2024-09-12
- GW PHARMACEUTICALS LIMITED 1999-04-21 → 2001-06-01
- TRADECHROME LIMITED 1999-01-29 → 1999-04-21
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- KPMG
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Directors have prepared the financial statements on a going concern basis as they do not intend to liquidate the Company or to cease its operations, and as they have concluded that the Company's financial position means that this is realistic. They have also concluded that there are no material uncertainties that could have cast significant doubt over its ability to continue as a going concern for at least a year from the date of approval of the financial statements ("the going concern period").”
Group structure
- JAZZ PHARMACEUTICALS OPERATIONS UK LIMITED · parent
- Jazz Financing UK Limited 100%
- GW UK Services Limited 100%
Significant events
- “The company name was changed from GW Pharma Limited to Jazz Pharmaceuticals Operations UK Limited on 12 September 2024.”
- “There have been no events or circumstances since the balance sheet date that would significantly affect the Company.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 25 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| PATEL, Alkesh | Secretary | 2024-04-03 | — | — |
| FLANAGAN, Amanda | Director | 2024-10-01 | Aug 1971 | Irish |
| MARCHETTI, Luca Giacomo | Director | 2023-04-28 | Jun 1972 | Italian |
| SPACKMAN, David James | Director | 2023-01-13 | Jan 1976 | British |
Show 25 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| DOODY, Aislinn Jane | Secretary | 2023-01-13 | 2024-04-03 |
| GEORGE, Adam David | Secretary | 2008-01-30 | 2020-12-18 |
| HATCHARD, John Rayner | Secretary | 1999-02-25 | 1999-07-26 |
| LAUGHTON, Jonathan Michael | Secretary | 1999-07-26 | 2008-01-30 |
| WARD, Iain Stuart | Secretary | 2020-12-18 | 2023-01-13 |
| SWIFT INCORPORATIONS LIMITED | Corporate Nominee Secretary | 1999-01-29 | 1999-02-18 |
| BROWN, Cabot | Director | 2013-02-19 | 2015-06-30 |
| BROWN, Cabot | Director | 2013-01-18 | 2013-01-18 |
| CAMPBELL, Adrian | Director | 2020-12-18 | 2023-01-01 |
| FORREST, Richard George | Director | 2007-03-15 | 2013-01-18 |
| GEORGE, Adam David | Director | 2008-01-30 | 2020-12-18 |
| GOVER, Justin David | Director | 1999-02-25 | 2015-06-30 |
| GUY, Geoffrey William, Dr | Director | 1999-02-25 | 2021-05-05 |
| HATCHARD, John Rayner | Director | 1999-02-25 | 2001-03-29 |
| KIRK, David Francis | Director | 2001-09-10 | 2012-06-01 |
| LAUGHTON, Jonathan Michael | Director | 1999-05-07 | 2008-01-30 |
| MACE, David Champion | Director | 2000-09-29 | 2007-03-20 |
| MOUNTFORD, Peter | Director | 2001-01-15 | 2006-02-09 |
| NOBLE, James Julian | Director | 2007-01-26 | 2018-03-01 |
| PEARCE, Samantha Jane Laura | Director | 2023-01-13 | 2024-10-01 |
| TOVEY, Christopher John | Director | 2012-10-01 | 2022-10-27 |
| WARD, Iain Stuart | Director | 2020-12-18 | 2023-01-13 |
| WHITTLE, Brian Anthony | Director | 1999-04-01 | 2008-03-18 |
| WRIGHT, Stephen, Dr | Director | 2005-03-22 | 2017-05-01 |
| INSTANT COMPANIES LIMITED | Corporate Nominee Director | 1999-01-29 | 1999-02-18 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Gw Pharmaceuticals Ltd | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 190 total filings
Material constitutional events — rename, articles re-file, resolution
- 2024-09-12 CERTNM Certificate change of name company PDF
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-01-29 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-11-21 | MR05 | mortgage | Mortgage charge part both with charge number | |
| 2025-11-21 | MR05 | mortgage | Mortgage charge part both with charge number | |
| 2025-11-21 | MR05 | mortgage | Mortgage charge part both with charge number | |
| 2025-10-03 | AA | accounts | Accounts with accounts type full | |
| 2025-02-04 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-12-30 | AA | accounts | Accounts with accounts type full | |
| 2024-11-27 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2024-10-02 | AP01 | officers | Appoint person director company with name date | |
| 2024-10-01 | TM01 | officers | Termination director company with name termination date | |
| 2024-09-12 | CERTNM | change-of-name | Certificate change of name company | |
| 2024-09-12 | AD01 | address | Change registered office address company with date old address new address | |
| 2024-04-18 | AP03 | officers | Appoint person secretary company with name date | |
| 2024-04-18 | TM02 | officers | Termination secretary company with name termination date | |
| 2024-02-01 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-01-23 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2024-01-16 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2024-01-08 | AA | accounts | Accounts with accounts type full | |
| 2023-06-26 | CH01 | officers | Change person director company with change date | |
| 2023-05-11 | AP01 | officers | Appoint person director company with name date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 5
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.